1. Fumitremorgin C Attenuates Osteoclast Formation and Function via Suppressing RANKL-Induced Signaling Pathways
   Yu Yuan et al, 2020, Frontiers in Pharmacology CrossRef
2. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
   Ursula B. McGovern et al, 2009, Molecular Cancer Therapeutics CrossRef
3. In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
   Gary J. Cheng et al, 2022, Exploration of Targeted Anti-tumor Therapy CrossRef
4. Identification of Inhibitors of ABCG2 by a Bioluminescence Imaging–Based High-Throughput Assay
   Yimao Zhang et al, 2009, Cancer Research CrossRef